In the current study, we successfully isolated and expanded CD13+CD44+ sphere cells (SCs) derived from clinical HCC samples and SK-Hep-1 cells, which demonstrated highly tumorigenic, chemo-resistant and metastatic potential. This evidence concerns the gene CD44 and hepatocellular carcinoma.